The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...

University of Edinburgh scientists developed a luminescent reporter that detected granzyme A activity in stool samples, ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from ...

CINCINNATI, Ohio — Meridian Bioscience’s European division will distribute in Italy a test for intestinal problems with plans to expand into France. The test, Quantum Blue Calprotectin, differentiates ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today ...

The Diagnostics Advisory Committee discussed the focus of the evaluation and the evidence available for faecal calprotectin testing. It noted that evidence existed on faecal calprotectin testing in ...